Brought to you by 
Ortho-Clinical gets rights to breast cancer genes from Corixa
22 Apr 2002
Executive Summary
Corixa (immunotherapeutics for cancer and autoimmune diseases) has licensed exclusive worldwide rights to its breast cancer genes to Advanced Diagnostic and Cellular Systems (ADCS), a cancer diagnostics and monitoring division of Johnson & Johnson company Ortho-Clinical Diagnostics.
Deal Industry
- In Vitro Diagnostics
-
In Vitro Diagnostics
- Molecular Diagnostics & Genetic Testing
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Ortho-Clinical gets rights to breast cancer genes from Corixa
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice